Affiliation:
1. Kommunarka Moscow Multidisciplinary Clinical Center; Pirogov Russian National Research Medical University
2. M. F. Vladimirsky Moscow Regional Research Clinical Institute
Abstract
The objective: to study changes and prognostic significance of the blood NT-proBNP in the patients with pulmonary sepsis.Subjects and Methods. The study included 34 patients aged 54.5 ± 2.9 years with pulmonary sepsis or septic shock. Lethality in the intensive care unit (ICU) was 47.1%. NT-proBNP, procalcitonin (PCT) levels, blood lactate and hemodynamic parameters were registered on the 1st day (stage 1) and on the 4th-5th day of the ICU stay (stage 2). Hemodynamics was assessed through transpulmonary thermodilution. The differences were considered statistically significant at p < 0.05.Results: At stage 1, NT-proBNP level was 5,220 [1,380‒17,850] pg/ml, did not decrease (p = 0.726) at stage 2 and amounted to 1,760 [631‒847] pg/ml. At stage 1, NT-proBNP correlated with extravascular lung water index (rho = 0.445; p = 0.038) and systolic pulmonary artery pressure (rho = 0.414; p = 0.023). At stage 2, NT-proBNP correlated with PCT (rho = 0.569; p = 0.003), blood lactate (rho = 0.525; p = 0.001), and mean arterial pressure to norepinephrine dosage ratio (rho = -0.422; p = 0.035). At stage 1, NT-proBNP was no predictor of lethality in the ICU: OR 1.0000; 95% CI 1.0000-1.0001. At stage 2, NT-proBNP > 4,260 pg/ml (sensitivity 87.5%, specificity 94.4%) was a predictor of lethality: OR 1.0004, 95% CI 1.0000-1.0008, p = 0.046 (AUC 0.893, 95% CI 0.732-0.974). Any increase of NT-proBNP level (> 0 pg/ml) between stages 2 and 1 was a predictor of lethality (sensitivity 87.5%, specificity 94.4%): OR 119.0, 95% CI 9.7432‒1,453.4241, p = 0.0002 (AUC 0.903, 95% CI 0.751-0.977).Conclusion: Patients with pulmonary sepsis are characterized by a significant increase of blood NT-proBNP. At stage 1, the biomarker correlated with pulmonary hypertension and moderate pulmonary edema and was no predictor of lethality. At stage 2, NT-proBNP correlated with the indices of infection and sepsis severity (procalcitonin, blood lactate, and mean arterial blood pressure/norepinephrine dosage ratio). At this stage, NT-proBNP levels greater than 4,000 pg/mL and/or any degree of increase in blood levels of the biomarker were both sensitive and specific predictors of a lethal outcome. Specific features of etiopathogenesis of BNP hyperproduction in pulmonary sepsis make it difficult to interpret the elevation of NT-proBNP as an indicator of septic cardiomyopathy but does not reduce its value as a sensitive and specific predictor of lethality.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine,Emergency Medicine
Reference45 articles.
1. Bautin A.E., Ksendikova A.V., Belolipetskiy S.S. et al. On the possibility of using pharmacological indices to predict the course of the post-operative period of cardiac surgery. Vestnik Intensivnoy Terapii Im. А.I. Saltanova, 2019, no. 2, pp. 66-74. (In Russ.) https://doi.org/10.21320/1818-474X-2019-2-66-74.
2. Kozlov I.A., Tyurin I.N., Avdeikin S.N. et al. Biomarker NTproBNP in patients with severe community acquired pneumonia. Obschaya Reanimatologiya, 2016, vol. 12, no. 3, pp. 24-33. (In Russ.) https://doi.org/10.15360/1813-9779-2016-3-24-33.
3. Komarov S.A., Kirov M.Yu. Evaluation of correlation between NT-proBNP biomarker with rates of hemodynamics and pulmonary extravascular water in patients with acute respiratory distress syndrome. Messenger of Anesthesiology and Resuscitation, 2015, vol. 12, no. 5, pp. 31-35. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-5-31-35.
4. Kuzkov V.V., Kirov M.Yu. Invasivny monitoring hemodinamiki v intensivnoy treapii i anesteziologii. [Invasive monitoring of hemodynamics in intensive care and anesthesiology]. 2nd ed., Arkhangelsk, Northern State Medical University, 2015, pp. 392. ISBN 978-5-91702-180-5.
5. Titova O.N., Kuzubova N.A., Aleksandrov A.L. et al. Features of central hemodynamics in patients with community-acquired pneumonia depending on the course of the disease and cardiovascular comorbidity. Terapevticheskiy Arkhiv, 2019, vol. 91, no. 12, pp. 29-34. (In Russ.) https://doi.org/10.26442/00403660.2019.12.000441.